Kerry to acquire part of the Lactase Enzymes Business of Novozymes and Chr. Hansen for €150m.

Kerry, a taste and nutrition partner for the food, beverage and pharmaceutical markets, agreed to acquire part of the Lactase Enzymes Business of Novozymes and Chr. Hansen for €150m. The Lactase Enzymes Business which includes NOLA® Products, further enhances Kerry's biotechnology solutions capability following the acquisitions of c-LEcta and Enmex. This acquisition adds enzyme technology which helps create lactose-free and sugar reduced dairy products, while preserving their authentic clean taste.